Abstract
Thirteen patients in the predialysis phase of chronic renal failure (CRF) were treated with calcitriol (0.25 μg/day) and 12 with placebo. After 1 year of study, an increase in bone mineral density in the calcitriol group measured by dual-energy X-ray absorptiometry was seen for the femoral neck and lumbar spine when compared to the placebo group (p

This publication has 0 references indexed in Scilit: